Epstein-Barr virus-containing epithelial cells from nasopharyngeal carcinoma produce interleukin 1 alpha.

No abstract is available for this paper.

• Publication year

  1987

• Venue

  Proceedings of the National Academy of Sciences of the United States of America

• Publication date

  1987-09-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1073/PNAS.84.17.6262PMID 2819868PMCID PMC299051
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Epstein-Barr virus-containing B-cell line produces an interleukin 1 that it uses as a growth factor.

  1987cited by this paper
• Preparation and characterization of polyclonal and monoclonal antibodies against human interleukin 1 alpha (IL 1 alpha).

  1987cited by this paper
• Lymphocyte subsets in tumour of patients with undifferentiated nasopharyngeal carcinoma: presence of lymphocytes with the phenotype of activated T cells.

  1987cited by this paper
• Autocrine models of B-lymphocyte growth. II. Interleukin-1 supports the proliferation of transformed lymphoblasts but not the stimulation of resting B cells triggered through their receptors for antigen.

  1986cited by this paper
• Human keratinocytes contain mRNA indistinguishable from monocyte interleukin 1 alpha and beta mRNA. Keratinocyte epidermal cell-derived thymocyte-activating factor is identical to interleukin 1

  1986cited by this paper
• Purification to homogeneity and amino acid sequence analysis of two anionic species of human interleukin 1

  1986cited by this paper
• Production of interleukin 1 by human endothelial cells.

  1986cited by this paper
• Interleukin 1 of the central nervous system is produced by ameboid microglia

  1986cited by this paper
• Cloning and characterization of the cDNAs for human and rabbit interleukin-1 precursor.

  1985cited by this paper
• Cloning, sequence and expression of two distinct human interleukin-1 complementary DNAs

  1985cited by this paper
• Interleukin 1 (IL 1)-dependent lymphokine production by human leukemic T cell line HSB.2 subclones.

  1985cited by this paper
• Association of Epstein-Barr virus with thymic carcinoma.

  1985cited by this paper
• Interleukin 1: an immunological perspective.

  1985cited by this paper
• B-cell-derived interleukin 1 (IL-1)-like factor. I. Relationship of production of IL-1-like factor to accessory cell function of Epstein-Barr virus-transformed human B-lymphoblast lines.

  1985cited by this paper
• Epidermal cytokines: properties of epidermal cell thymocyte-activating factor (ETAF).

  1984cited by this paper
• Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line

  1984cited by this paper
• Nucleotide sequence of human monocyte interleukin 1 precursor cDNA.

  1984cited by this paper
• Interleukin 1, a potential regulator of fibroblast proliferation.

  1982cited by this paper
• Purification to apparent homogeneity of murine interleukin 1.

  1981cited by this paper
• Subsets of human Ia-like molecules defined by monoclonal antibodies.

  1981cited by this paper
• T cell growth factor: parameters of production and a quantitative microassay for activity.

  1978cited by this paper
• Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

  1978cited by this paper
• Human leukocytic pyrogen: purification and development of a radioimmunoassay.

  1977cited by this paper
• Direct evidence for the presence of Epstein-Barr virus DNA and nuclear antigen in malignant epithelial cells from patients with poorly differentiated carcinoma of the nasopharynx.

  1974cited by this paper

• Nasopharyngeal carcinoma-associated inflammatory cytokines: ongoing biomarkers

  2024cites this paper
• Meta-Analysis illustrates possible role of lipopolysaccharide (LPS)-induced tissue injury in nasopharyngeal carcinoma (NPC) pathogenesis

  2021cites this paper
• PD-L1 expression in immune cells is a favorable prognostic factor for nasopharyngeal carcinoma

  2020cites this paper
• Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma

  2020cites this paper
• Pathogenesis of Nasopharyngeal Carcinoma

  2019cites this paper
• Immunotherapy for nasopharyngeal cancer-a review.

  2016cites this paper
• Evaluation of novel anti-tumoral strategies using peptide or monoclonal antibody immunotherapies

  2016cites this paper
• The Epstein-Barr virus latent membrane protein-1 (LMP1) 30-bp deletion and XhoI-polymorphism in nasopharyngeal carcinoma: a meta-analysis of observational studies

  2015cites this paper
• Effect of nasopharyngeal carcinoma-derived exosomes on human regulatory T cells.

  2015cites this paper
• RE: Effect of Nasopharyngeal Carcinoma-Derived Exosomes on Human Regulatory T Cells.

  2015cites this paper
• Lessons from rare tumors: hepatic lymphoepithelioma-like carcinomas.

  2015cites this paper
• Control of the Inflammatory Response Mechanisms Mediated by Natural and Induced Regulatory T-Cells in HCV-, HTLV-1-, and EBV-Associated Cancers

  2014cites this paper
• Co-infections, inflammation and oncogenesis: future directions for EBV research.

  2014cites this paper
• Cellular Interactions in Nasopharyngeal Carcinomas

  2013cites this paper
• carcinoma cells infected nasopharyngeal - exosomes released by Epstein-Barr virus containing - Blood diffusion and Th1-suppressive effects of galectin-9

  2013cites this paper
• Host-tumor interactions in nasopharyngeal carcinomas.

  2012cites this paper
• The role of the EBV-encoded latent membrane proteins LMP1 and LMP2 in the pathogenesis of nasopharyngeal carcinoma (NPC).

  2012cites this paper
• Association of IL‐1 polymorphisms and IL‐1 serum levels with susceptibility to nasopharyngeal carcinoma

  2011cites this paper
• Photodynamic therapy-mediated modulation of inflammatory cytokine production by Epstein–Barr virus-infected nasopharyngeal carcinoma cells

  2010cites this paper
• Blood diffusion and Th1-suppressive effects of galectin-9-containing exosomes released by Epstein-Barr virus-infected nasopharyngeal carcinoma cells.

  2009cites this paper
• Therapeutic Efficacy of Seliciclib in Combination with Ionizing Radiation for Human Nasopharyngeal Carcinoma

  2009cites this paper
• The role of the microenvironment on the regulation of Epstein-Barr virus latent gene expression

  2009cites this paper
• Selective homing of phenotypically lytic cells within nasopharyngeal carcinoma biopsies: Numerous CD8‐ and CD16‐positive cells in the tumor

  2007cites this paper
• Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral Latent Membrane Protein 1 and the immunomodulatory protein galectin 9

  2006cites this paper
• Expression of the interferon‐inducible chemokine IP‐10 (CXCL10), a chemokine with proposed anti‐neoplastic functions, in Hodgkin lymphoma and nasopharyngeal carcinoma

  2005cites this paper
• Epstein-Barr virus LMP1 status in relation to apoptosis, p53 expression and leucocyte infiltration in nasopharyngeal carcinoma.

  2004cites this paper
• Expression of interleukin-18 by nasopharyngeal carcinoma cells: a factor that possibly initiates the massive leukocyte infiltration.

  2004cites this paper
• Expression of Fas ligand in patients with evident skull base involvement of nasopharyngeal carcinoma.

  2002cites this paper
• [Correlation between Fas/Fas-ligand expression and apoptosis in undifferentiated nasopharyngeal carcinoma].

  2002cites this paper
• Interleukin-1beta expression in human gastric carcinoma with Epstein-Barr virus infection.

  2002cites this paper
• A distinct expression of CC chemokines by macrophages in nasopharyngeal carcinoma: implication for the intense tumor infiltration by T lymphocytes and macrophages.

  2001cites this paper
• Raf-induced transformation requires an interleukin 1 autocrine loop.

  2001cites this paper
• Epstein-Barr virus infection and human malignancies.

  2001cites this paper
• Expression of cytokine and chemokine genes in Epstein–Barr virus‐associated nasopharyngeal carcinoma: comparison with Hodgkin's disease

  2001cites this paper
• La biologie des carcinomes nasopharyngs en 2001: mise jour et perspectives

  2001cites this paper
• Epstein‐Barr virus infection and human malignancies

  2001cites this paper
• Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma

  2000cites this paper
• Control of apoptosis in Epstein Barr virus-positive nasopharyngeal carcinoma cells: opposite effects of CD95 and CD40 stimulation.

  1999cites this paper
• Analysis of the expression of Fas-L in nasopharyngeal carcinoma tissues.

  1999cites this paper
• Profile of cytokine expression in nasopharyngeal carcinomas: a distinct expression of interleukin 1 in tumor and CD4+ T cells.

  1999cites this paper
• Gastric and gingival localization of mucosa-associated lymphoid tissue (MALT) lymphoma. An immunohistochemical, virological and clinical case report.

  1999cites this paper
• Site‐specific Localization of Epstein‐Barr Virus in Pharyngeal Carcinomas

  1998cites this paper
• [Epstein-Barr virus infection in the pathogenesis of nasopharyngeal carcinoma].

  1998cites this paper
• An enhanced EBNA1 variant with reduced IR3 domain for long-term episomal maintenance and transgene expression of oriP-based plasmids in human cells

  1998cites this paper
• Monocyte chemoattractant protein‐1 (MCP‐1) expression in primary lymphoepithelioma‐like carcinomas (LELCs) of the lung

  1998cites this paper
• Die Epstein-Barr-Virusinfektion in der Pathogenese von Nasopharynxkarzinomen

  1998cites this paper
• Undifferentiated carcinoma of the nasopharynx and leukemoid reaction: report of case with literature review

  1997cites this paper
• Interleukin-1: basic science and clinical applications.

  1997cites this paper
• Use of Epstein-Barr Virus Nuclear Antigen-1 in Targeted Therapy of EBV-Associated Neoplasia

  1996cites this paper
• Epstein-Barr virus infection and the pathogenesis of nasopharyngeal carcinoma: viral gene expression, tumour cell phenotype, and the role of the lymphoid stroma.

  1996cites this paper
• The role of Epstein-Barr virus in the pathogenesis of Hodgkin's disease.

  1996cites this paper
• Expression of a B‐cell marker, CD24, on nasopharyngeal carcinoma cells

  1995cites this paper
• Expression of immune regulatory molecules in Epstein-Barr virus-associated nasopharyngeal carcinomas with prominent lymphoid stroma. Evidence for a functional interaction between epithelial tumor cells and infiltrating lymphoid cells.

  1995cites this paper
• Expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in undifferentiated nasopharyngeal carcinoma (lymphoepithelioma) and in malignant epithelial tumors.

  1994cites this paper
• Leukemoid reaction, bone marrow invasion, fever of unknown origin, and metastatic pattern in the natural history of advanced undifferentiated carcinoma of nasopharyngeal type: a review of 255 consecutive cases.

  1993cites this paper
• Clinical implications of the serum level of CD23 in patients with undifferentiated nasopharyngeal carcinoma.

  1993cites this paper
• Elevated serum cytokines in patients with malignancy and weight-loss.

  1993cites this paper
• Expression of a family of complementary-strand transcripts in Epstein-Barr virus-infected cells.

  1992cites this paper
• Elevated expression of ICAM1 (CD54) and minimal expression of LFA3 (CD58) in epstein‐barr‐virus‐positive nasopharyngeal carcinoma cells

  1992cites this paper
• Epstein-Barr virus infection in nasopharyngeal carcinoma.

  1992cites this paper
• Heterogeneity among human nasopharyngeal carcinoma cell lines for inflammatory cytokines mRNA expression levels.

  1992cites this paper
• Role of Cytokines in EBV-Infected Cell Growth

  1991cites this paper
• In situ production of interleukins in hyperplastic thymus from myasthenia gravis patients.

  1991cites this paper
• Differential expression of Epstein Barr viral transcripts for two proteins (TP1 and LMP) in lymphocyte and epithelial cells.

  1991cites this paper
• Cytotoxic potential despite impaired activation pathways in T lymphocytes infiltrating nasopharyngeal carcinoma

  1991cites this paper
• Interleukin 1: the first interleukin.

  1990cites this paper
• Testicular immunoregulatory factors.

  1990cites this paper
• Structure and regulation of the blast-2/CD23 antigen in epithelial cells from nasopharyngeal carcinoma.

  1990cites this paper
• Nasopharyngeal carcinoma: a medical oncology viewpoint. The Gustave Roussy experience.

  1990cites this paper
• Interleukin-1 and hematopoiesis.

  1989cites this paper
• Expression of EBV in the Nasopharyngeal Carcinoma-Derived Nude Mouse Tumour, C15

  1989cites this paper
• Transforming activity of nasopharyngeal carcinoma DNA detectable in mouse JB6 cells

  1989cites this paper
• Epstein-Barr virus (EBV)-containing nasopharyngeal carcinoma cells express the B-cell activation antigen blast2/CD23 and low levels of the EBV receptor CR2

  1989cites this paper
• EBV gene expression in an NPC‐related tumour.

  1989cites this paper
• Cytotoxic Tumor Infiltrating Lymphocytes in Nasopharyngeal Carcinoma

  1989cites this paper
• Nasopharyngeal cancer, undifferentiated type: the medical oncologist's viewpoint.

  1989cites this paper
• Expression and regulation of interleukin-1 mRNA and interleukin-1 receptors in human B-cell lines.

  1989cites this paper
• The effect of lipopolysaccharide on the production of GM-EA, GM-CSA, and PGE2 by human monocyte-derived lipid-containing macrophages.

  1988cites this paper
• Establishment and characterization of three transplantable EBV‐containing nasopharyngeal carcinomas

  1988cites this paper
• Oncogenes and growth factors.

  1988cites this paper
• Expression of the c‐fgr related transcripts in epstein‐barr virus‐associated malignancies

  1988cites this paper
• Maintenance of growth transformation with Epstein-Barr virus is mediated by secretion of autocrine growth factors in two serum-free B-cell lines

  1988cites this paper
• B-cell-derived interleukin-1.

  1987cites this paper